| dc.contributor.author | Shaw, G | |
| dc.contributor.author | Oliver, T | |
| dc.contributor.author | Kealy, R | |
| dc.contributor.author | Powles, T | |
| dc.contributor.author | Hillman, P | |
| dc.contributor.author | Cuzick, J | |
| dc.date.accessioned | 2020-11-27T15:58:49Z | |
| dc.date.available | 2020-11-27T15:58:49Z | |
| dc.date.issued | 2018-03-01 | |
| dc.identifier.citation | This article is a reprint of a previously published article. For citation purposes, please use the original publication details; YESJO, Volume 43, Issue 11, November 2017, Pages 2212–2213 | |
| dc.identifier.issn | 0748-7983 | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68786 | |
| dc.description.abstract | Abstract from Alan Edwards Poster Prize Presentation at the Joint BASO ∼ the Association for Cancer Surgery Annual Scientific Conference and the NCRI Cancer Conference –5th – 8th November 2017 | en_US |
| dc.format.extent | s13 | |
| dc.relation.ispartof | European Journal of Surgical Oncology | |
| dc.title | The PROVENT study, a multicentre double blind placebo controlled randomised trial to evaluate the effects of Vitamin D and aspirin on progression of low risk prostate cancer during active surveillance | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1016/j.ejso.2018.01.501 | |
| pubs.issue | Supplement 1 | |
| pubs.notes | Not known | en_US |
| pubs.volume | 44 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
